The convergence of precision medicine and gene editing heralds a paradigm shift in healthcare. Precision medicine, which tailors interventions to individual patients based on their molecular makeup, is poised to revolutionize disease management. Coupled with the potential of gene editing technologies like CRISPR, we stand at the threshold of modify